ROBERT SHORR

Corporate Board Profile

Tech Score: 0/100

BRAINSTORM CELL THERAPEUTICS INC.

Filing Date	Source Excerpt
2006-11-20	Robert Shorr Consists of 100,000 shares of restricted stock, which shares are subject to the Companys right to repurchase at a purchase price of par value ($0.00005), which repurchase right expires in three (3) equal annual installments beginning on May 27, 2006, and 100,000 shares of restricted stock, which shares are subject to the Companys right to repurchase at a purchase price of par value ($0.00005), which repurchase right expires in three (3) equal annual installments beginning on May 2, 2007.
2008-04-29	Dr. Shorr holds both a Ph.D. and a D.I.C. from the University of London, Imperial College of Science and Technology as well as a B.Sc. from the State University of New York.

Filing Date

Source Excerpt

2006-11-20

Robert Shorr Consists of 100,000 shares of restricted stock, which shares are subject to the Companys right to repurchase at a purchase price of par value ($0.00005), which repurchase right expires in three (3) equal annual installments beginning on May 27, 2006, and 100,000 shares of restricted stock, which shares are subject to the Companys right to repurchase at a purchase price of par value ($0.00005), which repurchase right expires in three (3) equal annual installments beginning on May 2, 2007.

2008-04-29

Dr. Shorr holds both a Ph.D. and a D.I.C. from the University of London, Imperial College of Science and Technology as well as a B.Sc. from the State University of New York.

Data sourced from SEC filings. Last updated: 2026-02-03